Martin Madaus
Chairman and Chief Executive Officer
Radiology
Ortho-Clinical Diagnostics KK A Johnson & Johnson Co
Japan
Biography
Dr. Martin Madaus, chairman and chief executive officer at Ortho Clinical Diagnostics (Ortho), has more than 25 years of experience in the diagnostics and life science industries. Prior to joining Ortho, Madaus served as executive chairman of Quanterix Corporation, and as senior health care advisor to The Carlyle Group. Earlier, Madaus was chairman, president and chief executive officer of Millipore Corporation (NYSE: MIL) from January 2005 to July 2010. He was president and chief executive officer of Roche Diagnostics Corporation North America from 2000 to 2004. Prior to that, he served as vice president of business development for Roche Molecular Diagnostics, and as the president of Roche Diagnostics Canada. Madaus started his career in the diagnostics industry in 1989 at Boehringer Mannheim in Germany and served in various roles in product management, marketing and general management in Germany, the United States and Canada. Madaus has extensive public and private company board experience and currently serves on the board of Quanterix Corporation. In addition, he served as a director of Mettler-Toledo International Inc. (NYSE: MTD), Covidien PLC (NYSE: COV), Millipore (NYSE:MIL), PPD International and Predictive Bioscience. Madaus received a Doctor of Veterinary Medicine degree from the University of Munich in Germany and a Ph.D. in veterinary medicine from the Veterinary School of Hanover in Germany.
Research Interest
Dr. Martin Madaus, chairman and chief executive officer at Ortho Clinical Diagnostics (Ortho), has more than 25 years of experience in the diagnostics and life science industries. Prior to joining Ortho, Madaus served as executive chairman of Quanterix Corporation, and as senior health care advisor to The Carlyle Group. Earlier, Madaus was chairman, president and chief executive officer of Millipore Corporation (NYSE: MIL) from January 2005 to July 2010. He was president and chief executive officer of Roche Diagnostics Corporation North America from 2000 to 2004. Prior to that, he served as vice president of business development for Roche Molecular Diagnostics, and as the president of Roche Diagnostics Canada. Madaus started his career in the diagnostics industry in 1989 at Boehringer Mannheim in Germany and served in various roles in product management, marketing and general management in Germany, the United States and Canada. Madaus has extensive public and private company board experience and currently serves on the board of Quanterix Corporation. In addition, he served as a director of Mettler-Toledo International Inc. (NYSE: MTD), Covidien PLC (NYSE: COV), Millipore (NYSE:MIL), PPD International and Predictive Bioscience. Madaus received a Doctor of Veterinary Medicine degree from the University of Munich in Germany and a Ph.D. in veterinary medicine from the Veterinary School of Hanover in Germany.
